chrisvoncsefalvay/vaers-outcomes huggingface dataset:
High temp over 104. Several hours after administration, no vomiting no diarrhea.
Very soon after vaccine, I developed severe headache, nausea, inflammed arm at injection site, fever, aching all over.
Lymph Nodes under armpit extremely swollen and painful. Unable to lift arm completely without pain
Hospitalized (1.11.22 - 1.13.22);  COVID-19 positive (1.11.22);  Fully vaccinated (no booster) Admission Date: 1/11/2022 Discharge Date: 01/13/2022 HOSPITAL COURSE: Per HPI: "Patient is a 79 y.o. male with a past medical history of oxygen-dependent chronic obstructive pulmonary disease, noncompliance, hypertension, choledocholithiasis, hepatitis-B, carotid stenosis who presents today with shortness of breath History was obtained from patient and also from patient's daughter.  Patient has been having trouble with shortness of breath and chest discomfort, orthopnea for the last 2 weeks.  It has been slowly worsening.  Patient is supposed to be on oxygen but does not wear it.  Patient is supposed to be on blood pressure medicine but he does not take it.  He has been vaccinated in March.  Given his noncompliance it has been frustrating to take care of him.  He denies cough, fevers to me, he denies nausea, vomiting, diarrhea, abdominal pain, daughter tells me that he typically denies all complaints.  He was admitted in March 2021 with choledocholithiasis, after the procedure he was drowsy and had to be intubated for 2 days.  He had some form of pulmonary edema. His oxygen saturation was 77% on room air, he was put on non-rebreather on which she was 100%, now is down to 99% on 4 L oxygen, blood pressure was 189/66, now down to 172/56 mm, pH 7.34, pCO2 72, bicarbonate 32, WBC 7.5, proBNP 179, troponin 15, EKG looks unremarkable, chest x-ray shows right greater than left streaky opacities suspicious for pneumonia versus asymmetric edema.  COVID-19 test is positive.  He has been given Solu-Medrol and nebulizer treatment.  Patient does not use inhalers or nebulizers at home although he supposed to   " Interim hospital course:  Patient hospitalized for acute hypoxic respiratory failure related to COVID-19 pneumonia with history of chronic obstructive pulmonary disease coming in additionally with chronic obstructive pulmonary disease exacerbation.  Patient was initially started on Solu-Medrol with rapid improvement in his oxygenation initially requiring 6 L weaned to room air within 24-48 hours of admission.  Patient transition to Decadron to complete a total of 10 days of steroids.  Initial CT angiogram negative for pulmonary embolism did show dilated pulmonary with suspicion for pulmonary arterial hypertension.  Patient should also have repeat follow-up CT scan in 3 months for regular opacity will defer to primary care physician on follow-up, recommend follow-up with primary care physician in the next 1 week.  Patient also coming in with hypertensive urgency started on Norvasc which he takes at home and blood pressure remained controlled throughout his stay.  Recommend outpatient follow-up for previously diagnosed hepatitis-B.  Care discussed with his daughter as well as the patient agreeable with discharge in medically stable for discharge on 01/13.
A LITTLE OVER AN HOUR FROM RECEIVING THE VACCINE I GOT A HEADACHE THAT HASN'T GONE AWAY AND ITS BEEN 6 DAYS NOW
had histoplasmosis a while back, said it was like fungus in the lungs; This spontaneous case was reported by a consumer and describes the occurrence of HISTOPLASMOSIS (had histoplasmosis a while back, said it was like fungus in the lungs) in an elderly female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Concurrent medical conditions included AFib (prior to vaccine).    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced HISTOPLASMOSIS (had histoplasmosis a while back, said it was like fungus in the lungs) (seriousness criterion medically significant). At the time of the report, HISTOPLASMOSIS (had histoplasmosis a while back, said it was like fungus in the lungs) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug was reported. Patient received Spikevax as first dose. No treatment drug was reported. Company comment This is a spontaneous case concerning an elderly female patient with no relevant medical history, who experienced the serious (due to medically significant) unexpected, event of Histoplasmosis, which occurred on an unknown date and with unknown latency in the context of receiving the first dose of mRNA-1273.222 (Original/Omicron BA.4/BA.5) vaccine. It was reported that patient had histoplasmosis a while back, said it was like fungus in the lungs. No further information was disclosed. The benefit-risk relationship of mRNA-1273.222 (Original/Omicron BA.4/BA.5) vaccine is not affected by this report.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 27-Mar-2023: Live significant Follow-up : Medical history and first dose details added.
This spontaneous report as received from a pharmacist refers to a 43 year old male patient with no drug reactions/allergies and no medical history. On an unspecified date in February 2015, the patient was vaccinated with a first dose of VARIVAX (Merck) 0.5 ml, subcutaneously (lot# and expiration date were not provided) as a mandatory vaccination. No concomitant medication was reported. In the evening of the date of administration, he experienced three inches of swelling at injection site. The patient did not seek medical attention. No treatment was given for the event. The patient recovered in three to four days on an unspecified date in 2015. The relatedness between the event and VARIVAX (Merck) was not provided. Additional information has been requested.
Rash developed on trunk, arms on day 7 after vaccination. Patient was seen 2/04/2021, treated with steroids and Benadryl, improved
Administered SARS-COV-2 (COVID) 2023-24 (6MO-11YR)(MODERNA), MRNA. The patient may have received 0.5mL dose. The manufacture provided 0.5mL per vial instated of 0.25mL/ vial.
Before receving the covid Pfizer vaccine, I rarely had headaches. I started having headaches periodically since the 2nd dose (January 2021). Afer the booster shot (the 3rd dose on 10/20/2021), other than the muscle pain on my left arm, I developed a low  grade fever (up to 99.7 F) after 26 hours of the injection. The fever lasted for 5 hrs. Two weeks later, all of sudden I had a headache at aournd noon. The headache persisted overnight. By the time I woke up, I felt nauseated due to the headache. I took two Ibuprofens and the headsche went away.
Patient received Moderna Covid vaccine on 10/21/22 which had expired on 10/19/2022. Vaccines removed from refrigerator and discarded. State notified. Patient notified and made aware that would need dose repeated. VAERS form Completed and Faxed.
This case was reported by a pharmacist via call center representative and described the occurrence of herpes zoster oticus in a 76-year-old male patient who received SHINGRIX for prophylaxis. On 15th June 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, 61 days after receiving SHINGRIX, the patient experienced herpes zoster oticus (serious criteria GSK medically significant). On an unknown date, the outcome of the herpes zoster oticus was recovered/resolved. It was unknown if the reporter considered the herpes zoster oticus to be related to SHINGRIX. Additional details were provided as follows: The pharmacist reported that the patient developed shingles in his ear approximately 2 months after receiving the 1st dose of SHINGRIX that lasted approximately 3 months. The pharmacist was unable to provide the lot number and expiration date of the SHINGRIX. The reported timing was as per the patient and was approximate. No further details were provided. The pharmacist consented to be followed up.
I had really bad flu like symptoms which I took TYLENOL for. I developed a cyst on the top of my foot about a week after the vaccine. It painful as it continued to grow. The podiatrist saw me on December 5th, 2022. She was able to drain the cyst a little. She advised to take TYLENOL for the pain and keep it wrapped. The symptoms have improved but I have not completely. I have migraines and plan to see a doctor regarding.
Pt recvd vax approx 115PM; approx 230PM pt was crying, unable to be consoled; began to have changes in skin color in extremeties, hands & feet began to tremble & began to breathe rapidly; t103.7, tempra drops were given & pt taken to ER;
May 15-16, 2021, I started having like flu like symptoms. On the May 17, 2021 I started feeling better from the flu like symptoms but I started to have a rash, headaches, and light headedness.  All of the symptoms were on and off everyday.  I contacted my doctor Dr. on June 9th, 2021, She gave me a video appointment on the June 10th, 2021 and describe the symptoms that I was having and she set me up for a follow-up appointment on June 14, 2021 at 3:30pm. Once I arrived she ordered blood work and the results for the blood test came back normal. On June 18, 2021 I sent my doctor a message that I was having a migraine and I was feeling fatigue. SO she told me to check my heart rate and it was 75 laying down and 130 standing up. June 21, 2021, my doctor said that it may be something like Pots.  I sent my doctor another message  June 29, 2021, That I felt really sick and had to lay down all day and I sent her a few more message about my heart rate on July 2, 2021.  On July 6, 2021, my doctor sent a message saying  that she wanted to do a full evaluation to confirm that it is Pots, for August 4, 2021.
Redness at injection site starting the same day.  Over the past few days reports pustules developed around vaccination site, redness, swelling, burning, soreness.
Exacerbation of eczema, increased dandruff, lethargy, bumps on body, cold chills
12/9 8am  itching in feet 12/9 throughout day, itching on torso 12/9 9pm - urticaria on abdomen, groin, inner thighs. Red, warm. Took Benadryl  12/10 - urticaria on chest, abdomen, back, back of legs. Took Benadryl  12/11 - urticaria on chest, abdomen, back, back of legs, groin, hands. Took Benadryl  12/12 - urticaria on chest, neck, ear, upper and lower back, abdomen, inner thighs, hands. Turning into dermatographic urticaria. Visit to urgent care. Began prednisone, Allegra, prilosec. Continued Benadryl at night. 12/13 - dermatographic urticaria on abdomen, legs, arms, hands. Continued medication regimen 12/14 - dermatographic urticaria on arms, lower legs, abdomen, neck. Itchy palms and soles of feet 12/15 - dermatographic urticaria on arms, thighs. Itchy palms and soles of feet 12/16 - dermatographic urticaria on arms, thighs. Itchy palms and soles of feet
The COVID-19 vaccine administered through vaccine administrator, between June 25 and July 30 came from the lot number 039K20A.  It was discovered that this particular lot was beyond its frozen expiration date by five (5) up to forty (40) days. A case was opened with Moderna (Case #: MOD21-126790).  Please refer to this case number if you would like to contact Moderna directly.  Moderna confirmed that the vaccine doses administered maintained the activity necessary to protect against the COVID-19 virus. Moderna also confirmed there is no danger to anyone's health from receiving a vaccine past its frozen expiration date. No adverse reactions were identified.
CHILLS, HEADACHE, BODY ACHE, FEVER (NORMAL IS ABOUT 97 AT LAST CHECK IT WAS 100.1), JOINT PAIN MORE THAN NORMAL, INJECTION SITE IS NORMAL- A LITTLE SORE BUT OTHERWISE NORMAL, BACK AND LEG MUSCLES CRAMPING ALL STARTED SINCE 4:45PM EST 10/09/2021. PRETTY CONSISTENT WITH WHAT FEELS LIKE A FEVER
was given with Bivalent Maroon Cap before completing the primary series / patient's second dose; This is a spontaneous report received from contactable reporter(s) (Nurse) from medical information team.  A 3-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 31Dec2022 as dose 2 (maroon cap), 0.2 ml single (Lot number: GK1667, Expiration Date: 03Jul2023) at the age of 3 years intramuscular, in left thigh for covid-19 immunisation. The patient didn't receive BNT162b2 (BNT162B2). The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (Dose 1, Unknown Manufacturer), for COVID-19 immunization. The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious) with onset 31Dec2022, outcome "unknown", described as "was given with Bivalent Maroon Cap before completing the primary series / patient's second dose". Additional information: The patient was 3 years, 7 months old. The patient was given with Bivalent Maroon Cap before completing the primary series. This was the patient's second dose, instead of giving the monovalent maroon cap as stated. Stated that this was a medication error. Had no issues that reporter was aware of at this point so would say that patient recovered completely. No treatment was given. The reporter was asking if they needed to give another bivalent vaccine for the third dose and for the recommendations. Event was reported as medically significant by the reporter. Vaccine was administered in the anterior lateral thigh on the left side.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Headache, Myalgia, Arthralgia, Fever, SkinRash, Rash, NauseaVomiting Swollen glands Narrative:
Student had gotten a flu vaccine on 12/01/20 from another provider. She came to the campus flu clinic on 1/26/21 and received another flu vaccine, her first dose being unbeknownst to the flu clinic staff.
February 15, 2021 started around 10:00am short runs of SVT.  Intermitten throughout the day. Worsening in the evening - feeling nauseated, chest pain, palipations and anxiety. Presented to the ER around 9pm.
Severe Dizziness, dry heaves, chills, weakness, lasting 2 1/2 days, 4 days after shot #2
Behavior changes.  Started spitting and hitting Mom 6-8 hours after immunization was given.  Behavior was terrible, hitting, kicking, spitting still 24 hours after immunization was given.
Patient developed cellulitis from reaction to injection - placed on antibiotic - KEFLEX per MD. Seen on 8/20/12.
This spontaneous report as received from a 77 year old female patient refers to herself. The patient did not have any pertinent medical history or drug reactions/allergies. Concomitant therapies included CELEXA, simvastatin, WELLBUTRIN and LEVOXYL. On 29-DEC-2011 the patient was vaccinated with ZOSTAVAX (route, dose and lot # were unknown) and developed a case of Shingles on Labor Day weekend, 2012 (05 MAY-2012). She had been dealing with the resulting Post herpetic neuralgia (PHN) since. She was in terrible pain. At first she sought medical attention via seeing her primary HCP (no demographics provided) and then she saw a dermatologist (no demographics provided). She was put on an unspecified antiviral drug (manufacturer unspecified) and OXYCONTIN (manufacturer unspecified) for treatment. She then started seeing a pain management specialist. He put her on Gabapentin (manufacturer unspecified). The patient could not sleep or walk and the nerve pain was horrendous. She would now be seeing a neurological pain management specialist (no demographics provided) and was trying physical therapy. The outcome of event was reported as not recovered/not resolved. Lab Diagnostics Studies Performed: MRIs (results not provided). Upon internal review, patient can not walk was determined to be disabling. Additional information has been requested.
This case involves a patient with unknown demography who experienced got sick (illness) and was in bed for 5 days, while he/she received vaccine INFLUENZA VACCINE. Medical history, past medical treatments, past vaccinations, concomitant medication and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number and expiration date were not reported) via unknown route at an unknown administration site for prophylactic vaccination. On an unknown date, the patient got sick and was in bed for 5 days (illness), (unknown latency) following the administration of INFLUENZA VACCINE. It was reported that each time patient got those shots he/she got sick, then patient was told if he/she hadn't gotten the shot it would have been worse. Last shot, in bed for 5 days. That is how patients body reacted. Laboratory data was not reported. It was not reported if the patient received any corrective treatment or not. The outcome of the event was unknown at the time of reporting. There will be no information on the batch number for this case.
2nd of the Moderna Covid-19 vaccine given to 3 patients after excursion; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (2nd of the Moderna Covid-19 vaccine given to 3 patients after excursion) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jul-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (2nd of the Moderna Covid-19 vaccine given to 3 patients after excursion). On 22-Jul-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (2nd of the Moderna Covid-19 vaccine given to 3 patients after excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported by the reporter.  No treatment medications were reported by the reporter.
This spontaneous report as received from an office manager refers to a female patient of unknown age. On 01-AUG-2017, the patient was vaccinated with PNEUMOVAX 23 Lot # N011305 and expiration date on 20-JAN-2019, 1 DF, intramuscularly for prophylaxis. In August 2017, the patient experienced injection site erythema and injection site pain. The patient visited the physician but it was unknown if she received any treatment for the adverse events. No any laboratory study was performed. The outcome of injection site erythema and injection site pain was reported as not recovered/not resolved.  This is one of several cases received from the same reporter.; Sender's Comments:  US-009507513-1708USA004754: US-009507513-1708USA002956:
17 year old patient given single dose Janssen COVID-19 vaccination. Underage, but incarcerated as an adult.
Heart palpitations, heart rate increase to 170/110 within a minute of getting the second dose administered
4:30 PM started itching. Approximately 8 PM, hives noted on back, arms and chest. In AM, hives over entire body so called MD; went to ER. Received IV medication, O2, and Breathing prescription. Sent home on anti-puritic and cortisone. Nurse follow up on 06/08/04 states: Bronchspasm, wheeze, rash.
Patient got flu shot and Shingrix shot on 10/22/2020  I mix the Shingrix shot but did not realize that syringe was empty and give her empty shot.  I told the patient what has happened and went to Pharmacy got the full syringe with shingrix and give her the shot. I was very busy did not realize that. Also I know being busy is not an excuse, but honestly I did see that.
Approximately 10-15 minutes after injection, she developed tachycardia with documented BP 181/93, HR 153, Resp 24, p.ox 99% in clinic area.  Taken to emergency critical care bed.
patient passed out today ,, around 28 hours after getting covid janssen vaccine.. also patient has headache, fever,chills
Patient states he developed redness, swelling and pain to injection site. pain was progressively worsening and shoot up into neck starting day of vaccination.
Patient became pale, felt weak, dizzy. Vital signs stable, 100% O2 on Room air
2 days of fever and gut pain (48hr). Diarrhea after 48hrs and into third day.
urticaria 1 day after vaccine, given benadryl and urticaria fully resolved the next day without any further doses.
Some leakage from the syringe druing administration; it went down the arm; Some leakage from the syringe druing administration; it went down the arm; A spontaneous report was received from a consumer who was a 68-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and who during drug administration, experienced some leakage from the syringe occurred and it went down her arm  (vaccine underdose and device connection issue).  The patient's medical history were not provided. Concomitant medications reported included multivitamins, levothyroxine sodium, anastrozole, propranolol and oxazepam.   On 04-Mar-2021, the patient received their second of two planned doses of mRNA-1273 (Lot number: 040A21A) intramuscularly in the right deltoid muscle for prophylaxis of COVID-19 infection.   On 04-Mar-2021, during vaccine administration, some leakage from the syringe occurred and it went down her arm. The head nurse over the facility confirms that it should not matter how much she got because the second shot was like a booster.  Treatmment information was not provided  The patient received both scheduled doses of mRNA-1273; therefore, action taken with mRNA-1273 in response to the events was not applicable.   The outcome of events, vaccine underdose and device connection issue, was considered recovered/resolved.; Reporter's Comments: This report refers to a case of a 68-year-old, female patient who experienced some leakage from the syringe occurred and it went down her arm  ((Syringe issue and Incomplete dose administered) for mRNA-1273 (Lot number: 040A21A). There were no reported AEs associated with this case of syringe issue and incomplete dose administered.
Left Upper Arm/Injection site swollen (45 mm), red, hot Treatment: ice, Ibuprofen
Pt called several hours after the administration on 2/22/06 c/o pain and difficulty moving of left arm. Symptoms were at the highest level the first 3 days after immunization and she states today 7/11/06 that she has steadily improved since. Has recovered for the most part, presenting 7/11/06 with vague discomfort in the lower aspect of left arm, 3 to 4 inches above elbow.
One week subsequent to vaccine, eye stye in left eye.  On 13th day, eye stye in right eye.  Blurred vision in both eyes, itchy eyes.  Watery nose- need to blow nose regularly.
I had the injection at 4:45pm on 11/11/2021 ,started to have diarrhea at 9:00pm followed by 2 episodes of vomiting which all ended by midnight. I also experienced muscle and joint pain for 3 days. My first shot was  feb. 1st with only a sore arm my second shot  on March 01, 2021 I had chills, headache and minor muscle aches the next morning , this last one was much worse. I must mention that I had a flu vaccine on 11/9/2021 and was told that it would not interfere with the  moderna vaccine.
Inflamed, red, circular area on right arm, area burns and itches at times. No pain event reported to me 5-7-14 at 12:00 pm. I told patient to have her doctor look at rash.